These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 16627818)
21. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation. Knight S; Johns EJ Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621 [TBL] [Abstract][Full Text] [Related]
22. Effect of cyclooxygenase on "window of implantation" in mouse. Pakrasi PL; Jain AK Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):147-53. PubMed ID: 18029163 [TBL] [Abstract][Full Text] [Related]
23. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors? Bergmann F; Breinig M; Höpfner M; Rieker RJ; Fischer L; Köhler C; Esposito I; Kleeff J; Herpel E; Ehemann V; Friess H; Schirmacher P; Kern MA Am J Gastroenterol; 2009 Jan; 104(1):171-81. PubMed ID: 19098866 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor. Okumura T; Murata Y; Hizue M; Matsuura T; Naganeo R; Kanai Y; Murase A; Sakakibara A; Fujita I; Nakao K Eur J Pharmacol; 2006 Jun; 539(1-2):125-30. PubMed ID: 16690052 [TBL] [Abstract][Full Text] [Related]
25. Pilot randomized phase II study of celecoxib in oral premalignant lesions. Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950 [TBL] [Abstract][Full Text] [Related]
26. The role of cyclooxygenase in the feline pulmonary vascular bed. Kaye AD; Hoover JM; Kaye AJ; Ibrahim IN; Phelps J; Baluch A Am J Ther; 2007; 14(3):247-52. PubMed ID: 17515698 [TBL] [Abstract][Full Text] [Related]
27. Arthritis develops but fails to resolve during inhibition of cyclooxygenase 2 in a murine model of Lyme disease. Blaho VA; Mitchell WJ; Brown CR Arthritis Rheum; 2008 May; 58(5):1485-95. PubMed ID: 18438879 [TBL] [Abstract][Full Text] [Related]
28. The COX-2 story: is any drug completely "safe?". DuBois RN Gastroenterology; 2006 Jan; 130(1):6. PubMed ID: 16401461 [No Abstract] [Full Text] [Related]
29. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis. Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239 [TBL] [Abstract][Full Text] [Related]
30. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis. Chen M; Boilard E; Nigrovic PA; Clark P; Xu D; Fitzgerald GA; Audoly LP; Lee DM Arthritis Rheum; 2008 May; 58(5):1354-65. PubMed ID: 18438856 [TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 selective inhibitors and prostate cancer: what is the clinical benefit? DuBois RN J Clin Oncol; 2006 Jun; 24(18):2691-3. PubMed ID: 16782907 [No Abstract] [Full Text] [Related]
32. Localization of cyclooxygenase-2 in mice testis and assessment of its possible role through suppressing its expression using nimesulide: a preferential cyclooxygenase-2 inhibitor. Balaji T; Ramanathan M; Padmanabhan Menon V Prostaglandins Leukot Essent Fatty Acids; 2007 Jun; 76(6):341-8. PubMed ID: 17624748 [TBL] [Abstract][Full Text] [Related]
33. Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats. Matsunaga A; Kawamoto M; Shiraishi S; Yasuda T; Kajiyama S; Kurita S; Yuge O Eur J Pharmacol; 2007 Jan; 554(1):12-7. PubMed ID: 17112505 [TBL] [Abstract][Full Text] [Related]
34. The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity. Lee IO; Seo Y Anesth Analg; 2008 Mar; 106(3):972-7, table of contents. PubMed ID: 18292448 [TBL] [Abstract][Full Text] [Related]
35. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Targownik LE; Metge CJ; Leung S; Chateau DG Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634 [TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant therapy with celecoxib to women with early stage breast cancer. Tfayli A; Yang J; Kojouri K; Kesserwan C; Jafari M; Ozer H Neoplasma; 2008; 55(2):122-6. PubMed ID: 18237249 [TBL] [Abstract][Full Text] [Related]
37. Apoptosis of murine lupus T cells induced by the selective cyclooxygenase-2 inhibitor celecoxib: molecular mechanisms and therapeutic potential. Yang P; Zhang Y; Ping L; Gao XM Int Immunopharmacol; 2007 Nov; 7(11):1414-21. PubMed ID: 17761345 [TBL] [Abstract][Full Text] [Related]
38. The pain game. Wadman M Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159 [No Abstract] [Full Text] [Related]
39. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Choi SH; Aid S; Bosetti F Trends Pharmacol Sci; 2009 Apr; 30(4):174-81. PubMed ID: 19269697 [TBL] [Abstract][Full Text] [Related]
40. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]